BioCytics Achieves Significant Regulatory Milestone with FDA INTERACT Meeting Success BioCytics announces a key milestone with the FDA INTERACT meeting, setting the stage for its cell therapy platform aimed at combating solid tumors.

BioCytics Achieves Significant Regulatory Milestone with FDA INTERACT Meeting Success #USA #FDA #Immunotherapy #Huntersville #BioCytics

BioCytics Secures G-Rex Grant to Enhance Cancer Treatment Technology BioCytics has received a $100,000 G-Rex grant from ScaleReady to advance its innovative cell-based therapy for cancer treatment. This funding supports the development of immune cell manufacturing processes.

BioCytics Secures G-Rex Grant to Enhance Cancer Treatment Technology #USA #Huntersville #BioCytics #G-Rex_Grant #ScaleReady